Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
16
Since Q1 2021
Holdings of NTLA by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−50−100.0%Sold outHolders
Q4 202550$450<0.1%00.0%UnchangedHolders
Q3 202550$864<0.1%00.0%UnchangedHolders
Q2 202550$469<0.1%00.0%UnchangedHolders
Q1 202550$356<0.1%00.0%UnchangedHolders
Q4 202450$583<0.1%00.0%UnchangedHolders
Q3 202450$1.03K<0.1%00.0%UnchangedHolders
Q2 202450$1.12K<0.1%00.0%UnchangedHolders
Q1 202450$1.38K<0.1%00.0%UnchangedHolders
Q4 202350$1.52K<0.1%00.0%UnchangedHolders
Q3 202350$1.58K<0.1%00.0%UnchangedHolders
Q2 202350$2.04K<0.1%00.0%UnchangedHolders
Q1 202350$1.86K<0.1%+50NewHolders
Q1 20220$00.0%−62−100.0%Sold outHolders
Q4 202162$7.33K<0.1%−85−57.8%ReducedHolders
Q3 2021147$19.7K<0.1%+12+8.9%AddedHolders
Q2 2021135$21.9K<0.1%−190−58.5%ReducedHolders
Q1 2021325$26.1K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.